Some exciting developments in HIV prevention were presented this past July at the IAS Conference on HIV Science. Initially, prevention of HIV transmission was only safe sex practices. Then in 2012 the drugs we know as PrEP and PEP were approved to prevent the transmission of HIV. PrEP is a prevention drug that can be taken daily the prevent transmission for people who are more likely to come into contact with HIV, like someone whose sexual partner is HIV positive. The NIAID is funding research into new ways to administer PrEP that do not require daily pills. This infographic describes the current research!
Read more about prevention efforts and advances at http://bit.ly/36ndIEs
Infographic titled Long-Acting Forms of HIV Prevention
For some people, long-acting forms of HIV prevention may be more desirable than a daily pill
Section titled HIV Prevention today- and in the future
Taking an oral dose of the medication Truvado once a day, every day can prevent HIV infection.
NIAID-funded researchers are developing and testing alternative HIV prevention products that could be inserted, injected, infused, or implanted from once a month (monthly)… to once a year (yearly) in people who commit to using the products on an ongoing basis.
New section titled NIAID is funding research on 4 types of long-acting HIV prevention
Intravaginal Ring (IVR): Polymer ring inserted into the vagina releases antiretroviral drug over time
Implant: Device implanted in the body releases antiretroviral drug over time
Injectable: Long-acting antiretroviral drug is injected into the body
Antibody: Antibody is infused or injected into the body
New Heading titled At What Stage Is This Research
Implant is in design and development and manufacturing and safety study stages
Ring and antibody are in manufacturing and safety study and human study stages, and injectable is in human study stage.